array(3) { ["company_details"]=> array(13) { ["name"]=> string(26) "Bio-RAD Laboratories, Inc." ["slug"]=> string(33) "001cd-us-bio-rad-laboratories-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/9d1c28c2-1b47-4093-8ed2-5151f3fe7920" ["description"]=> string(867) "Since Bio-Rad was founded 70 years ago, we have continued to provide the healthcare industry with innovative and useful products that help life science researchers accelerate the discovery process and medical diagnostic labs obtain faster, better results. Throughout our existence, we have built long-lasting customer relationships that help advance our research and development efforts in the introduction of new products and solutions. Today, Bio-Rad is a global leader, with a team of over 8,000 employees and a global network of operations that serves our life science research and clinical diagnostics customers, advancing science and saving lives, together. #Biotechnology #Biotech #STEM #Research #Biology #Chemistry #Science #PeerReviewed #Diabetes #CancerResearch #HIVResearch #Laboratory #BioRad #Cancer #DiabetesResearch #AIDSResearch #ClinicalDiagnostics" ["address_street"]=> string(20) "1000 Alfred Nobel Dr" ["address_place"]=> string(8) "Hercules" ["address_region"]=> string(10) "California" ["founding_date"]=> string(10) "1952-02-08" ["website_domain"]=> string(11) "bio-rad.com" ["website_url"]=> string(23) "https://www.bio-rad.com" ["industry_codes"]=> array(3) { [0]=> string(42) "In Vitro and In Vivo Diagnostic Substances" [1]=> string(33) "Laboratory Analytical Instruments" [2]=> string(47) "Electromedical and Electrotherapeutic Apparatus" } ["employee_count"]=> int(7900) ["article_count"]=> int(684) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(73) "Scope Fluidics (WSE:SCP) - Stock Price, News & Analysis - Simply Wall St" ["snippet_en"]=> string(155) "Research Scope Fluidics' (WSE:SCP) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more." ["url"]=> string(72) "https://simplywall.st/stocks/pl/healthcare/wse-scp/scope-fluidics-shares" ["image_url"]=> string(78) "https://images.businessradar.com/articles/6d70ed64-378e-46e9-bb90-37dead2c5896" ["source"]=> string(13) "simplywall.st" ["publication_date"]=> string(10) "2024-02-26" ["categories"]=> array(5) { [0]=> string(9) "Valuation" [1]=> string(15) "Market Movement" [2]=> string(12) "Stock Market" [3]=> string(18) "General Investment" [4]=> string(24) "Stock Research & Ratings" } } [1]=> array(7) { ["title_en"]=> string(80) "Bio-Rad Laboratories (NYSE:BIO) - Stock Price, News & Analysis - Simply Wall St" ["snippet_en"]=> string(162) "Research Bio-Rad Laboratories' (NYSE:BIO) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more." ["url"]=> string(85) "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bio/bio-rad-laboratories" ["image_url"]=> string(78) "https://images.businessradar.com/articles/8141cc14-f185-4b4b-8269-b0c9b83caef8" ["source"]=> string(13) "simplywall.st" ["publication_date"]=> string(10) "2024-01-24" ["categories"]=> array(5) { [0]=> string(12) "Board Change" [1]=> string(10) "Executives" [2]=> string(15) "Market Movement" [3]=> string(12) "Stock Market" [4]=> string(24) "Stock Research & Ratings" } } [2]=> array(7) { ["title_en"]=> string(84) "Zacks Research Weighs in on Bio-Rad Laboratories, Inc.'s Q1 2025 Earnings (NYSE:BIO)" ["snippet_en"]=> string(300) "Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Stock analysts at Zacks Research cut their Q1 2025 EPS estimates for Bio-Rad Laboratories in a research note issued to investors on Tuesday, January 16th. Zacks Research analyst R. Anand now forecasts that the medical research company will pos" ["url"]=> string(89) "https://www.marketbeat.com/instant-alerts/nyse-bio-analyst-earnings-estimates-2024-01-19/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/4c2cc902-3ad5-47d1-82b6-b5f42dbe6540" ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2024-01-19" ["categories"]=> array(7) { [0]=> string(13) "Credit Rating" [1]=> string(5) "R & D" [2]=> string(24) "Quarterly/Annual Figures" [3]=> string(17) "Academic Research" [4]=> string(9) "Investors" [5]=> string(12) "Stock Market" [6]=> string(24) "Stock Research & Ratings" } } [3]=> array(7) { ["title_en"]=> string(45) "Scope Fluidics: Turning micro-flows into cash" ["snippet_en"]=> string(277) "We are starting to issue recommendations for Scope Fluidics with a BUY recommendation and a fair value valuation of PLN 235.8/share (42% growth potential compared to the current price). Scope Fluidics became a role model among Polish medtech start-ups after the sale of PCR|ONE" ["url"]=> string(79) "https://www.fxmag.pl/artykul/scope-fluidics-zmieniajac-mikroprzeplywy-w-gotowke" ["image_url"]=> string(78) "https://images.businessradar.com/articles/89884aa2-69dc-4b21-86ef-787a1ffc3db2" ["source"]=> string(8) "fxmag.pl" ["publication_date"]=> string(10) "2023-11-10" ["categories"]=> array(4) { [0]=> string(25) "Start-up's & New Business" [1]=> string(10) "Divestment" [2]=> string(9) "Valuation" [3]=> string(24) "Stock Research & Ratings" } } [4]=> array(7) { ["title_en"]=> string(52) "Bio-Rad Shares Drop After Company Reports 3Q Results" ["snippet_en"]=> string(160) "By Stephen Nakrosis Shares of Bio-Rad Laboratories were trading lower in the after-hours market following the release of third-quarter financial results that..." ["url"]=> string(95) "https://www.marketwatch.com/story/bio-rad-shares-drop-after-company-reports-3q-results-0d9c70ab" ["image_url"]=> string(78) "https://images.businessradar.com/articles/3bebe02f-4333-46c5-bde4-e8e5d9bb24c2" ["source"]=> string(15) "marketwatch.com" ["publication_date"]=> string(10) "2023-10-26" ["categories"]=> array(7) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Quarterly/Annual Figures" [2]=> string(14) "Issuing Shares" [3]=> string(21) "Financial Performance" [4]=> string(15) "Market Movement" [5]=> string(12) "Stock Market" [6]=> string(24) "Stock Research & Ratings" } } [5]=> array(7) { ["title_en"]=> string(80) "HighTower Advisors LLC Sells 142 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)" ["snippet_en"]=> string(217) "HighTower Advisors LLC reduced its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 2.2% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission." ["url"]=> string(119) "http://www.defenseworld.net/2023/09/08/hightower-advisors-llc-sells-142-shares-of-bio-rad-laboratories-inc-nysebio.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/70bb08f6-8b4a-443a-8583-9cc819a13978" ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2023-09-08" ["categories"]=> array(8) { [0]=> string(10) "Divestment" [1]=> string(31) "Financial Update/Profit Warning" [2]=> string(24) "Quarterly/Annual Figures" [3]=> string(9) "Valuation" [4]=> string(14) "Issuing Shares" [5]=> string(12) "Stock Market" [6]=> string(18) "General Investment" [7]=> string(24) "Stock Research & Ratings" } } [6]=> array(7) { ["title_en"]=> string(82) "Timothy S. Ernst Sells 2,350 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) Stock" ["snippet_en"]=> string(252) "Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) EVP Timothy S. Ernst sold 2,350 shares of the stock in a transaction that occurred on Wednesday, August 30th. The stock was sold at an average price of $395.60, for a total value of $929,660.00." ["url"]=> string(119) "http://www.defenseworld.net/2023/09/02/timothy-s-ernst-sells-2350-shares-of-bio-rad-laboratories-inc-nysebio-stock.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/dfacb159-fe6e-4a94-bd88-9bc8949d674e" ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2023-09-02" ["categories"]=> array(5) { [0]=> string(10) "Divestment" [1]=> string(24) "Quarterly/Annual Figures" [2]=> string(14) "Issuing Shares" [3]=> string(12) "Stock Market" [4]=> string(24) "Stock Research & Ratings" } } [7]=> array(7) { ["title_en"]=> string(95) "American Century Companies Inc. Acquires 34,008 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)" ["snippet_en"]=> string(231) "American Century Companies Inc. grew its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 261.5% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission." ["url"]=> string(132) "http://www.defenseworld.net/2023/08/31/american-century-companies-inc-acquires-34008-shares-of-bio-rad-laboratories-inc-nysebio.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/6d5bd8ea-cdf3-4c11-9ab8-b487869e91d0" ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2023-08-31" ["categories"]=> array(8) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(11) "Acquisition" [2]=> string(24) "Quarterly/Annual Figures" [3]=> string(14) "Issuing Shares" [4]=> string(13) "Credit Rating" [5]=> string(12) "Stock Market" [6]=> string(18) "General Investment" [7]=> string(24) "Stock Research & Ratings" } } [8]=> array(7) { ["title_en"]=> string(128) "S&P 500 paper Bio-Rad Laboratories stock: This is how much of a loss an early Bio-Rad Laboratories investment would have yielded" ["snippet_en"]=> string(86) "Investors would have lost so much by investing in Bio-Rad Laboratories stock early on." ["url"]=> string(174) "https://www.finanzen.ch/nachrichten/aktien/s-p-500-papier-bio-rad-laboratories-aktie-so-viel-verlust-haette-ein-fruehes-bio-rad-laboratories-investment-eingebracht-1032586242" ["image_url"]=> string(78) "https://images.businessradar.com/articles/665de5fc-a62e-45de-84b9-f1bf903d1e3c" ["source"]=> string(11) "finanzen.ch" ["publication_date"]=> string(10) "2023-08-28" ["categories"]=> array(3) { [0]=> string(12) "Stock Market" [1]=> string(18) "General Investment" [2]=> string(24) "Stock Research & Ratings" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(66) } [1]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(51) } [2]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(32) } [3]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(30) } [4]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(26) } [5]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(24) } [6]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(23) } [7]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(20) } [8]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(20) } [9]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(19) } [10]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(19) } [11]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(18) } [12]=> array(2) { ["name"]=> string(18) "Ecological Impacts" ["count"]=> int(15) } [13]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(14) } [14]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(14) } [15]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(13) } [16]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(10) } [17]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(10) } [18]=> array(2) { ["name"]=> string(10) "New Market" ["count"]=> int(9) } [19]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(9) } [20]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(8) } [21]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(7) } [22]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(7) } [23]=> array(2) { ["name"]=> string(27) "Business Model & Innovation" ["count"]=> int(7) } [24]=> array(2) { ["name"]=> string(11) "Competition" ["count"]=> int(7) } [25]=> array(2) { ["name"]=> string(16) "Case Settlements" ["count"]=> int(6) } [26]=> array(2) { ["name"]=> string(13) "Credit Rating" ["count"]=> int(5) } [27]=> array(2) { ["name"]=> string(15) "Business Ethics" ["count"]=> int(5) } [28]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(5) } } } 001cd-us-bio-rad-laboratories-inc